Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care
VitaPCR™ RT-PCR test reaches sensitivity and specificity close to 100% (99,3% and 94,7%, respectively). With this 1.2 kg device, the test is simple and fast, obtaining results in 20 min like in the rapid antigen tests. The assay evaluates three gene targets: N gene of the viral nucleocapsid, a conserved gene sequence among Coronaviruses, and […]
VitaPCR™ SARS-CoV-2 Gen 2 Assay receives approval for continued distribution in the United Kingdom
On 28 October 2022, Credo Diagnostics Biomedical received confirmation from the UK Health Security Agency that the VitaPCR™ SARS-CoV-2 Gen 2 Assay has been approved under the requirements set out in The Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021. VitaPCR™ SARS-CoV-2 Gen 2 Assay is a rapid molecular in-vitro diagnostic solution, using real-time […]
